NCT06712017View on ClinicalTrials.gov

Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 22, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma Non-Resectable
Interventions
DEVICE

Yttrium-90 (Y-90) resin microspheres

selective internal radiation therapy

Trial Locations (6)

Unknown

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

The First Affiliated Hospital of Jinan University, Jinan

Xi'An International Medical Center Hospital, Xi’an

No.1 Affiliated Hospital of Xian Jiaotong University, Xi’an

Beijing Tsinghua Changgung Hospital, Beijing

The Third Affiliated Hospital of Naval Medical University, Shanghai

All Listed Sponsors
lead

GrandPharma (China) Co., Ltd.

INDUSTRY